Australian Statistics on Medicines 2010 | Pharmaceutical Benefits Scheme (PBS)

Table 1 - Musculo-Skeletal System

M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES
M01AB05	DICLOFENAC
	P	1299J	Tablet 25mg (enteric coated)	0.10	GM	79,100	1,010,483
	P	1300K	Tablet 50mg (enteric coated) 50	0.10	GM	906,895	10,001,304
	P	1302M	Suppository 100mg 40	0.10	GM	14,719	354,508
	A	16918	Tablet 25mg 20	0.10	GM	11,212	—
	A	16971	Tablet 25mg 10	0.10	GM	3,042	—
	A	17454	Tablet 25mg 30	0.10	GM	12,426	—
	A	18567	Tablet 50mg 20	0.10	GM	139,904	—
	A	18726	Suppository 50mg 10	0.10	GM	600	—
	A	20662	Tablet 25mg (enteric coated) 30	0.10	GM	2,738	—
	A	20718	Tablet 25mg 30	0.10	GM	556	—
	A	21270	Tablet 50mg (enteric coated) 50	0.10	GM	1,412	—
	P	5076E	Tablet 25mg (enteric coated)	0.10	GM	215	2,108
	P	5077F	Tablet 50mg (enteric coated)	0.10	GM	1,453	14,622
	P	5362F	Tablet 50mg (enteric coated) 50	0.10	GM	1,381	22,177
	P	5365J	Tablet 50mg (enteric coated) 50	0.10	GM	640	761
M01AB55	DICLOFENAC with MISOPROSTOL
	P	4190M	Tablet 50mg 200ug 60	—	—	1,414	54,801
M01AB01	INDOMETHACIN
	P	2454E	Capsule 25mg	0.10	GM	296,550	3,521,904
	P	2757D	Suppository 100mg	0.10	GM	53,991	1,176,314
	P	5377B	Capsule 25mg 100	0.10	GM	205	3,318
	P	5378C	Suppository 100mg 40	0.10	GM	161	4,110
	P	5379D	Capsule 25mg 100	0.10	GM	211	—
M01AB15	KETOROLAC
	A	13986	Ampoule 30mg per 1mL 5	30.00	MG	1,020	—
	A	14188	Tablet 10mg 30	30.00	MG	1,204	—
	A	14950	Ampoule 10mg per 1mL	30.00	MG	242	—
M01AB02	SULINDAC
	P	2047R	Tablet 100mg	0.40	GM	3,189	51,425
	P	2048T	Tablet 200mg	0.40	GM	9,985	152,763
OXICAMS
M01AC06	MELOXICAM
	P	8561N	Tablet 7.5mg	15.00	MG	314,172	6,467,489
	P	8562P	Tablet 15mg	15.00	MG	885,908	23,952,592
	P	8887R	Capsule 7.5mg 30	15.00	MG	391,396	8,052,500
	P	8888T	Capsule 15mg 30	15.00	MG	820,085	22,126,663
M01AC01	PIROXICAM
	P	1895R	Dispersible tablet 10mg 50	20.00	MG	3,655	45,367
	P	1896T	Dispersible tablet 20mg 25	20.00	MG	57,759	703,640
	P	1897W	Capsule 10mg	20.00	MG	26,649	332,459
	P	1898X	Capsule 20mg	20.00	MG	124,038	1,509,730

M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS
	P	5203W	Capsule 10mg	20.00	MG	222	2,658
PROPIONIC ACID DERIVATIVES
M01AE01	IBUPROFEN
	A	13267	Tablet 200mg 12	1.20	GM	116	—
	A	13268	Tablet 200mg 24	1.20	GM	3,126	—
	A	13372	Tablet 200mg 48	1.20	GM	2,244	—
	A	15401	Susp 0.1/5mL 100mL	1.20	GM	427	—
	A	21048	Tablet 200mg 50	1.20	GM	3,048	—
	P	3190X	Tablet 400mg	1.20	GM	200,186	2,891,395
	P	3192B	Tablet 400mg 30	1.20	GM	219,043	2,013,771
	P	3198H	Tablet 200mg	1.20	GM	3,368	38,859
	P	5123P	Tablet 400mg	1.20	GM	407	4,526
	P	5124Q	Tablet 400mg 30	1.20	GM	7,867	71,185
	P	5368M	Tablet 400mg 100	1.20	GM	719	12,230
M01AE51	IBUPROFEN with CODEINE
	A	17716	Tablet 200mg/12.8mg 48	—	—	6,840	—
	A	18882	Tablet 200mg/12.8mg 48	—	—	3,226	—
	A	18887	Tablet 200mg/12.8mg 48	—	—	3,621	—
	A	19136	Tablet 200mg/12.5mg 12	—	—	6,375	—
	A	19137	Tablet 200mg/12.5mg 12	—	—	24,315	—
	A	19138	Tablet 200mg/12.5mg 12	—	—	9,179	—
	A	19795	Tablet 200mg/12.8mg 75	—	—	3,593	—
	A	20613	Tablet 200mg/12.8mg 48	—	—	1,370	—
	A	21001	Tablet 200mg/12.5mg 15	—	—	1,955	—
	A	21002	Tablet 200mg/12.5mg 30	—	—	24,307	—
	A	21099	Tablet 200mg/12.8mg 30	—	—	32,522	—
	A	21114	Tablet 200mg/12.8mg 30	—	—	12,567	—
	A	21115	Tablet 200mg/12.8mg 24	—	—	2,503	—
	A	21127	Tablet 200mg/12.8mg 24	—	—	208	—
	A	21132	Tablet 200mg/12.8mg 24	—	—	156	—
	A	21135	Tablet 200mg/12.8mg 24	—	—	330	—
	A	21165	Tablet 200mg/12.8mg 24	—	—	116	—
M01AE03	KETOPROFEN
	P	1588N	Suppository 100mg	0.15	GM	1,929	48,732
	P	1590Q	Capsules 200mg (sustained release) 28	0.15	GM	144,168	2,816,866
	P	5136H	Capsule 200mg (sustained release)	0.15	GM	214	3,687
M01AE02	NAPROXEN
	A	11401	Tablet 275mg 12	0.50	GM	276	—
	P	1614Y	Tablet 750mg (sustained release) 28	0.50	GM	94,409	1,166,139
	P	1615B	Tablet 1g (sustained release) 28	0.50	GM	225,070	3,225,580
	P	1658G	Oral suspension 125mg per 5mL 474mL	0.50	GM	828	66,919
	P	1659H	Tablet 500mg	0.50	GM	168,994	2,175,379
	P	1674D	Tablet 250mg	0.50	GM	43,173	565,129

M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS
	P	1795L	Tablet 550mg 50	0.50	GM	40,227	525,249
	P	5177L	Tablet 500mg	0.50	GM	173	2,085
	P	5179N	Tablet 1g (sustained release)	0.50	GM	115	1,523
	P	5346J	Tablet 500mg 50	0.50	GM	238	3,062
	P	5348L	Tablet 1g (sustained release) 28	0.50	GM	370	5,779
M01AE11	TIAPROFENIC ACID
	P	2103Q	Tablet 300mg	600.00	MG	9,151	160,809
FENAMATES
M01AG01	MEFENAMIC ACID
	A	11611	Capsule 250mg 20	1.00	GM	358	—
	P	1824B	Capsule 250mg	1.00	GM	47,423	859,046
COXIBS
M01AH01	CELECOXIB
	A	17093	Capsule 200mg 10	0.20	GM	1,973	—
	P	8439E	Capsule 100mg 60	0.20	GM	233,556	7,506,837
	P	8440F	Capsule 200mg 60	0.20	GM	1,287,206	42,556,625
M01AH05	ETORICOXIB
	A	20525	Tablet 30mg 30	60.00	MG	2,054	—
	A	20526	Tablet 60mg 30	60.00	MG	5,531	—
	A	20527	Tablet 120mg 10	60.00	MG	3,374	—
OTHER ANTIINFL./ANTIRHEUMATIC AGENTS, NON-STEROIDS
M01AX12	PENTOSAN-POLY SULFATE SODIUM
	A	14955	Capsule 100mg 100	—	—	154	—
SPECIFIC ANTIRHEUMATIC AGENTS
GOLD PREPARATIONS
M01CB03	AURANOFIN
	P	1095P	Tablet 3mg	6.00	MG	2,713	175,500
M01CB01	SODIUM AUROTHIOMALATE
	P	2016D	Injection 10mg	2.40	MG	118	7,731
	P	2017E	Injection 20mg	2.40	MG	241	23,522
	P	2018F	Injection 50mg	2.40	MG	1,408	193,696
PENICILLAMINE
M01CC01	PENICILLAMINE
	P	2721F	Tablet 125mg	0.50	GM	414	15,630
	P	2838J	Tablet 250mg	0.50	GM	3,838	195,840

M02 - TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN ANTIINFL. PREP., NON-STEROIDS FOR TOPICAL USE
M02AA15	DICLOFENAC
	A	14860	Gel 50g 1	—	—	2,919	—
	A	14861	Gel 100g 1	—	—	12,377	—
	A	14979	Gel 20g 1	—	—	704	—
M02AA10	KETOPROFEN
	A	14949	Gel 2.5% 60g 1	—	—	230	—
M02AA07	PIROXICAM
	A	15090	Gel 0.5% 25g 1	—	—	170	—
	A	15091	Gel 0.5% 50g 1	—	—	896	—
CAPSAICIN and SIMILAR AGENTS
M02AB	CAPSAICIN
	A	15579	Cream 0.025% 45g	—	—	303	—
PREPARATIONS with SALICYLIC ACID DERIVATIVES
M02AC	METHYL SALICYLATE
	A	12931	Cream 100g 1	—	—	1,597	—
	P	4022Q	Compound Cream APF 100gm	—	—	2,429	34,666
	P	4023R	Ointment BP 100gm	—	—	994	12,467
	P	4026X	Liniment APF 100gm	—	—	1,297	12,887
M02AC	METHYL SALICYLATE with MENTHOL with EUCALYPTUS OIL
	A	11224	Cream 125g 1	—	—	921	—

M03 - MUSCLE RELAXANTS

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM MUSCLE RELAXANTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES
M03BC01	ORPHENADRINE CITRATE
	A	11353	Tablet 100mg 100	0.12	GM	7,047	—
M03BC51	ORPHENADRINE CITRATE with PARACETAMOL
	A	11354	Tablet 35mg-450mg 100	0.12	GM	4,682	—
	A	21041	Tablet 35mg-450mg 24	0.12	GM	5,791	—
OTHER CENTRALLY ACTING AGENTS
M03BX01	BACLOFEN
	P	2729P	Tablet 10mg	50.00	MG	103,082	3,552,683
	P	2730Q	Tablet 25mg	50.00	MG	52,016	3,307,782
	P	6284R	Intrathecal injection 10mg in 5mL 10	0.55	MG	133	87,907
MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
DANTROLENE AND DERIVATIVES
M03CA01	DANTROLENE SODIUM
	P	1779P	Capsule 25mg	0.10	GM	5,456	366,583
	P	1780Q	Capsule 50mg	0.10	GM	2,477	187,357

M04 - ANTIGOUT PREPARATIONS

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM ANTIGOUT PREPARATIONS ANTIGOUT PREPARATIONS PREPARATIONS INHIBITING URIC ACID PRODUCTION
M04AA01	ALLOPURINOL
	P	2600W	Tablet 100mg	0.40	GM	287,890	3,757,692
	P	2604C	Tablet 300mg	0.40	GM	826,110	8,577,193
PREPARATIONS INCREASING URIC ACID EXCRETION
M04AB01	PROBENECID
	P	1940D	Tablet 500mg	1.00	GM	18,677	1,400,192
PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM
M04AC01	COLCHICINE
	P	1227N	Tablet 500ug	1.00	MG	201,093	2,242,576
	P	3410L	Tablet 500ug 30	1.00	MG	37,975	430,126

M05 - DRUGS FOR TREATMENT OF BONE DISEASES

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM DRUGS FOR TREATMENT OF BONE DISEASES DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION BISPHOSPHONATES
M05BA04	ALENDRONIC ACID
	P	8090T	Tablet 40mg	10.00	MG	12,198	1,643,044
	P	8511Y	Tablet 70mg alendronic acid 4	10.00	MG	711,273	32,863,889
M05BA02	CLODRONIC ACID
	P	8132B	Capsule equivalent to 400mg sodium clodronate	1.60	GM	666	226,692
	P	8265B	Capsule equivalent to 800mg sodium clodronate	1.60	GM	12,350	4,831,032
M05BA01	DISODIUM ETIDRONATE
	P	2920Q	Tablet 200mg	0.40	GM	498	66,273
M05BA03	DISODIUM PAMIDRONATE
	P	6223M	Vial pdr for IV infuse 90mg amp solvent 10mL	60.00	MG	2,678	1,189,002
	P	6289B	Concentrated injection 90mg in 10mL	60.00	MG	440	178,360
	P	8209C	2 Vials pdr for IV infuse 30mg 2 amp solvent 10mL	60.00	MG	416	113,788
	P	8462J	Concentrated injection 30mg in 10mL	60.00	MG	189	42,616
	P	8463K	Concentrated injection 60mg in 10mL	60.00	MG	183	50,268
M05BA06	IBANDRONIC ACID
	P	9357L	Tablet 50mg (as ibandronate sodium monohydrate) 28	5.00	MG	5,449	1,860,022
	P	9619G	Inj for I.V. infusion equiv 6mg (as ibandronate sodium monohydrate) in 6mL	6.00	MG	1,303	492,601
M05BA07	RISEDRONIC ACID
	P	4444X	Tablet 35mg 4	5.00	MG	2,823	150,553
	P	8481J	Tablet 5mg 28	5.00	MG	9,311	495,642
	P	8482K	Tablet 30mg 28	5.00	MG	3,173	965,271
	P	8621R	Tablet 35mg	5.00	MG	346,829	18,458,744
	P	9391G	Tablet 150mg 1	5.00	MG	247,184	14,069,540
M05BA05	TILUDRONIC ACID
	P	8267D	Tablet 200mg	0.40	MG	503	153,153
M05BA08	ZOLEDRONIC ACID
	P	6371H	Injection concentrate I.V. infusion 4mg (as monohydrate) in 5mL	4.00	MG	21,001	10,463,262
	P	9288W	Solution for I.V. infusion 5mg (as monohydrate) in 100mL	4.00	MG	22,261	12,994,751
	P	9350D	Solution for I.V. infusion 5mg (as monohydrate) in 100mL	4.00	MG	529	311,296
BISPHOSPHONATES, COMBINATIONS
M05BB05	ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE
	P	9351E	Pack 4 tablets equiv 70mg alendronic acid with 140ug colecalciferol, 48 tablets calcium carbonate 1.25g	10.00	MG	47,351	2,169,327
M05BB03	ALENDRONIC ACID and COLECALCIFEROL
	P	9012H	Tablet equiv to 70mg alendronic with 70ug Colecal	—	—	436,820	20,196,881
	P	9183H	Tablet equiv to 70mg alendronic with 140ug Colecal	—	—	500,936	23,136,793
M05BB01	ETIDRONIC ACID AND CALCIUM
	P	8056B	28 tabs 200mg and 76 tabs calcium (equiv 500mg)	—	—	7,644	539,815
M05BB04	RISEDRONIC ACID and CALCIUM CARBONATE with COLECALCIFEROL
	P	4380M	4 tablets 35mg and 24 sachets granules 2.5g-22ug	—	—	1,768	94,193
	P	9147K	4 tablets 35mg and 24 sachets granules 2.5g-22ug	—	—	325,827	17,360,601
M05BB02	RISEDRONIC SODIUM with CALCIUM CARBONATE
	P	4059P	Pack containing 4 tablets 35mg and 24 tabs 1.25g	—	—	3,097	165,544

M05 - DRUGS FOR TREATMENT OF BONE DISEASES

				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
MUSCULO-SKELETAL SYSTEM DRUGS FOR TREATMENT OF BONE DISEASES DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
	P	8899J	Pack containing 4 tablets 35mg and 24 tabs 1.25g	—	—	467,015	24,887,189
OTHER DRUGS AFFECTING BONE STRUCTURE
M05BX04	DENOSUMAB
	P	5457F	Injection 60mg in 1 ml prefilled syringe	0.33	MG	155	47,253
M05BX03	STRONTIUM RANELATE
	P	3036T	Granules for oral suspension 2g, 28 Sachets	2.00	GM	298,009	15,869,745